CN302 Phase 2 Lithium Trial on Neuropathic Pain after spinal cord injury |
Neuropathic pain is a common complication after spinal cord injury and difficult to treat. Our CN102a study suggested the lithium carbonate tablet might have pain relieve effect, this trial is to evaluate the efficacy of 6 week course of lithium in spinal cord injured patients suffered from moderate to serious neuropathic pain for more than 6 weeks. The study sites are open for subject recruitment.
Study Sites : China Rehabilitation Research Center (Beijing) and Xi'an Jiaotong University Second Hospital (Xi'an)
Principal Investigators : Jianjun LI and Xijing HE
No. of Subjects (estimated): 60
Sponsorship: Hong Kong Spinal Cord Injury Fund and local research grants
For more details, please refer to:
Clinicaltrials.gov: NCT01855594
What should I do if I would like to participate in the trials of ChinaSCINet?
To learn as much as possible about the clinical trial and then
contact the investigator directly. You may also leave your basic
information and contact here ( Submit a Form). The investigators may retrieve the data
and contact you if they think you might be suitable candidate for the
trial.
To read more:
About Clinical Research
About Lithium and Cord Blood Cells
|
|